pmc logo image
Logo of agpsychBioMed Central web siteReference to the article.Search.Manuscript submission.Registration.See also Annals of General Hospital Psychiatry Journal in PMC.Journal front page.
Journal List > Ann Gen Psychiatry > v.8; 2009

Formats:
Ann Gen Psychiatry. 2009; 8: 15.
Published online 2009 June 18. doi: 10.1186/1744-859X-8-15.
PMCID: PMC2705371
Copyright © 2009 Geitona et al; licensee BioMed Central Ltd.
Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study
Maria Geitona,1 Hara Kousoulakou,2 Markos Ollandezos,3 Kostas Athanasakis,3 Sotiria Papanicolaou,corresponding author4 and Ioannis Kyriopoulos3
1Department of Economics, University of Thessaly, Magnissias 96, Dionyssos 14576, Greece
2Institute for Economic and Industrial Research, Tsami Karatasi 11, 117 42 Athens, Greece
3Department of Health Economics, National School of Public Health, Aleksandra's Avenue 196, 11521 Athens, Greece
4Janssen-Cilag Pharmaceutical SACI, Eirinis Avenue 56, 15121 Pefki, Athens, Greece
corresponding authorCorresponding author.
Maria Geitona: geitona/at/econ.uth.gr; Hara Kousoulakou: kousoul/at/iobe.gr; Markos Ollandezos: markolan/at/gmail.com; Kostas Athanasakis: k.athanasakis/at/gmail.com; Sotiria Papanicolaou: spapanic/at/jacgr.jnj.com; Ioannis Kyriopoulos: nsph-kyr/at/ath.forthnet.gr
Received June 17, 2009; Accepted June 18, 2009.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Small right arrow pointing to: This corrects the article "Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study" in volume 7 on page 16.
Abstract
Correction to Geitona M, Kousoulakou H, Ollandezos M, Athanasakis K, Papanicolaou S and Kyriopoulos I: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study. Annals of General Psychiatry 2008, 7:16. This correction reports changes in the values listed for Ziprasidone and Aripiprazole in Table Ten.
Correction
Following the publication of our article [1], it has come to our attention that there was an error with the values listed for Ziprasidone and Aripiprazole in Table Ten. Table Ten should therefore appear as shown in this correction (Table 1).
Table 1
Table 1
Mean annual number of stable days and cost per patient by pharmaceutical treatment.
References
  • Geitona M, Kousoulakou H, Ollandezos M, Athanasakis K, Papanicolaou S, Kyriopoulos I. Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study. Annals of General Psychiatry. 2008;7:16. doi: 10.1186/1744-859X-7-16. [PubMed]
Articles from Annals of General Psychiatry are provided here courtesy of
BioMed Central
See more articles cited in this paragraph